Stuttgart - Delayed Quote EUR
Adaptimmune Therapeutics PLC (473A.SG)
0.2200
-0.0060
(-2.65%)
As of 8:00:42 AM GMT+2. Market Open.
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
-73,206
-73,206
-140,880
-141,769
10,729
Investing Cash Flow
-58,952
-58,952
176,538
89,137
75,800
Financing Cash Flow
78,749
78,749
880
12,867
3,288
End Cash Position
93,206
93,206
147,017
109,602
151,666
Income Tax Paid Supplemental Data
1,525
1,525
4,000
630
535
Interest Paid Supplemental Data
2,092
2,092
--
--
--
Capital Expenditure
-2,720
-2,720
-4,880
-29,740
-8,781
Issuance of Capital Stock
29,172
29,172
624
12,817
2,529
Issuance of Debt
49,500
49,500
--
--
--
Free Cash Flow
-75,926
-75,926
-145,760
-171,509
1,948
12/31/2021 - 8/28/2017
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
IMR.SG AC Immune SA
1.3560
0.00%
2VSA.DU Verastem Inc. R
6.15
-3.15%
3G0.BE Altimmune Inc
4.3900
-0.48%
PH4.DU CStone Pharmaceuticals
0.3300
+2.48%
F6T.SG Fate Therapeutics Inc
1.1470
-4.18%
MDG1.F Medigene AG
0.1685
-23.06%
TBPH Theravance Biopharma, Inc.
9.45
+1.50%
OCS Oculis Holding AG
17.89
+0.62%
VOR Vor Biopharma Inc.
0.7591
+8.13%
SCPH scPharmaceuticals Inc.
2.6000
-0.38%